Kei S. Tolliver
Founder at VLP Therapeutics LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ryuji Ueno | M | 70 |
VLP Therapeutics LLC
 VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 28 years |
| Wataru Akahata | M | - |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 12 years |
| Misako Nakata | F | - |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 12 years |
| Sachiko Kuno | M | 69 |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthias Alder | M | 59 | 3 years | |
| Peter Greenleaf | M | 54 | 4 years | |
| Timothy Maudlin | M | 73 | 7 years | |
| Stanley G. Miele | M | 60 | - | |
| Matthew Donley | M | 55 | 4 years | |
| Anthony C. Celeste | M | 85 | 8 years | |
| Gayle Robert Dolecek | M | 81 | - | |
| Michael J. Jeffries | M | 80 | - | |
| Elizabeth Cho-Fertikh | M | - |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 5 years |
| Taryn R. Joswick | F | - | - | |
| Hidetoshi Mine | M | 73 | - | |
| Charles S. Hrushka | M | 72 | - | |
| Myra Louise | M | - | - | |
| V. Molina | F | 75 | 3 years | |
| Mariam Morris | F | 55 | 5 years | |
| P. Christopher Holland | M | - | - | |
| Brad E. Fackler | M | 70 | 4 years | |
| Steven Caffé | M | - | 4 years | |
| Cary Claiborne | M | 64 | 3 years | |
| Peter Kiener | M | 72 | 4 years | |
| Ronald W. Kaiser | M | 70 | 1 years | |
| Jan Smilek | M | 57 | 3 years | |
| John C. Wright | M | 76 | 1 years | |
| Diana Halim | F | 47 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 28 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kei S. Tolliver
- Personal Network
